NIH added to BRAC-1 patent

WASHINGTON - Resolution of a patent dispute between the University of Utah and NIH over discovery of the BRAC-1 gene paves the way for commercialization of a diagnostic for breast cancer.

Last week, Myriad Genetics Inc. filed an amended patent application listing as co-inventors two NIH scientists who were listed as co-authors of the original scientific paper describing the gene. The original paper, and the patent application, listed investigators from Myriad, the University and Eli Lilly and Co...